Dr. Robert Molpus, M.D
Claim this profileClinical Neuroscience Solutions, Inc.
Studies Depression
Studies Major Depressive Disorder
9 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Robert Molpus, M.D is currently running
Investigational Drug
for Bipolar Depression
This trial is testing a new medication called SEP-4199 CR to see if it can help adults aged 18-65 who have depression from Bipolar I disorder. The study will compare the effects of the medication to see if it reduces symptoms of depression. SEP-4199 has shown antidepressant efficacy in a previous study for bipolar depression.
Recruiting1 award Phase 35 criteria
Psilocybin
for Depression
Approximately 240 eligible adult participants (≥18 years old) who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) criteria for Major Depressive Disorder (MDD) will be enrolled. Participants will be randomly assigned to receive a single oral dose of Psilocybin 25 mg, Psilocybin 5 mg, or inactive placebo. The purpose of this study is to evaluate the efficacy, safety, and tolerability of Psilocybin 25 mg versus placebo in adults with MDD, as assessed by the difference between groups in change in depressive symptoms from Baseline to Day 43 post-dose, and to characterize the durability of initial treatment effect and subsequent response to optional Psilocybin 25 mg re-administration(s) during the 1-year Follow-up Period.
Recruiting1 award Phase 3
More about Robert Molpus, M.D
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Robert Molpus, M.D has experience with
- Placebo
- Serdexmethylphenidate (SDX) And Dexmethylphenidate (d-MPH)
- SEP-4199 CR 200 Mg
- SEP-4199 CR 400 Mg
- NOE-105
- TNX-102 SL
Breakdown of trials Robert Molpus, M.D has run
Depression
Major Depressive Disorder
Attention Deficit Hyperactivity Disorder (ADHD)
Bipolar Depression
Childhood Onset Fluency Disorder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Molpus, M.D specialize in?
Robert Molpus, M.D focuses on Depression and Major Depressive Disorder. In particular, much of their work with Depression has involved treating patients, or patients who are undergoing treatment.
Is Robert Molpus, M.D currently recruiting for clinical trials?
Yes, Robert Molpus, M.D is currently recruiting for 2 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Robert Molpus, M.D has studied deeply?
Yes, Robert Molpus, M.D has studied treatments such as Placebo, Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), SEP-4199 CR 200 mg.
What is the best way to schedule an appointment with Robert Molpus, M.D?
Apply for one of the trials that Robert Molpus, M.D is conducting.
What is the office address of Robert Molpus, M.D?
The office of Robert Molpus, M.D is located at: Clinical Neuroscience Solutions, Inc., Orlando, Florida 32801 United States. This is the address for their practice at the Clinical Neuroscience Solutions, Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.